ACCD - Accolade Inc Stock Price, Fair Value and News

9.40USD+0.05 (+0.53%)Market Closed

Market Summary

USD9.40+0.05

Market Closed

0.53%

ACCD Stock Price

View Fullscreen

ACCD RSI Chart

ACCD Valuation

Market Cap

723.8M

Price/Earnings (Trailing)

-5.9

Price/Sales (Trailing)

1.86

EV/EBITDA

-6.57

Price/Free Cashflow

-25.15

ACCD Price/Sales (Trailing)

ACCD Profitability

EBT Margin

-31.47%

Return on Equity

-28.23%

Return on Assets

-15.63%

Free Cashflow Yield

-3.98%

ACCD Fundamentals

ACCD Revenue

Revenue (TTM)

388.5M

Rev. Growth (Yr)

9.26%

Rev. Growth (Qtr)

2.59%

ACCD Earnings

Earnings (TTM)

-122.7M

Earnings Growth (Yr)

47.17%

Earnings Growth (Qtr)

35.83%

Breaking Down ACCD Revenue

Last 7 days

11.3%

Last 30 days

-1.5%

Last 90 days

-20.4%

Trailing 12 Months

-41.4%

How does ACCD drawdown profile look like?

ACCD Financial Health

Current Ratio

2.35

ACCD Investor Care

Shares Dilution (1Y)

6.35%

Diluted EPS (TTM)

-1.71

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	363.1M	370.8M	380.1M	388.5M
2022	310.0M	336.0M	350.4M	357.9M
2021	170.4M	194.0M	230.5M	275.5M
2020	132.5M	139.6M	146.8M	155.6M
2019	94.8M	104.2M	113.7M	123.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Accolade Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 18, 2024	singh rajeev	sold	-3,132	8.823	-355	chief executive officer
Apr 18, 2024	barnes stephen h.	sold	-961	8.823	-109	chief financial officer
Apr 18, 2024	hilton michael w	acquired	-	-	331	-
Apr 18, 2024	cavanaugh robert n	sold	-1,244	8.823	-141	president
Apr 17, 2024	singh rajeev	acquired	-	-	933	chief executive officer
Apr 17, 2024	cavanaugh robert n	acquired	-	-	510	president
Apr 17, 2024	barnes stephen h.	acquired	-	-	414	chief financial officer
Apr 11, 2024	cavanaugh robert n	sold	-2,238	8.849	-253	president
Apr 11, 2024	barnes stephen h.	sold	-2,344	8.849	-265	chief financial officer
Apr 11, 2024	singh rajeev	sold	-5,902	8.849	-667	chief executive officer

Which funds bought or sold ACCD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Gradient Investments LLC	sold off	-100	-925	-	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-74.86	-87,000	24,000	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	added	0.79	-37,239	271,694	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	49,506	415,786	-%
Apr 19, 2024	Cutler Group LLC / CA	reduced	-37.54	-66,000	78,000	0.03%
Apr 19, 2024	Sumitomo Mitsui Trust Holdings, Inc.	reduced	-5.82	-3,857,520	17,790,400	0.01%
Apr 18, 2024	ARK Investment Management LLC	reduced	-17.52	-22,905,900	58,824,700	0.41%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	new	-	86,544	86,544	-%
Apr 18, 2024	Requisite Capital Management, LLC	sold off	-100	-254,012	-	-%
Apr 18, 2024	Miracle Mile Advisors, LLC	added	0.03	-87,653	602,045	0.01%

Are Funds Buying or Selling ACCD?

Are funds buying ACCD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ACCD

No. of Funds

Unveiling Accolade Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	bellevue group ag	5.0%	4	SC 13G/A
Feb 13, 2024	vanguard group inc	6.99%	5,326,212	SC 13G/A
Feb 09, 2024	brown advisory inc	7.6%	5,892,043	SC 13G/A
Jan 29, 2024	ark investment management llc	8.93%	6,805,208	SC 13G/A
Jan 26, 2024	blackrock inc.	7.4%	5,660,665	SC 13G/A
Jan 16, 2024	jpmorgan chase & co	8.2%	6,411,973	SC 13G/A
Feb 14, 2023	bellevue group ag	5.1%	3,677,277	SC 13G
Feb 10, 2023	ark investment management llc	7.59%	5,458,916	SC 13G/A
Feb 09, 2023	vanguard group inc	6.83%	4,916,397	SC 13G/A
Feb 09, 2023	brown advisory inc	6.9%	4,988,021	SC 13G

Recent SEC filings of Accolade Inc

View All Filings

Date Filed	Form Type	Document
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 18, 2024	144	Notice of Insider Sale Intent
Apr 18, 2024	144	Notice of Insider Sale Intent
Apr 18, 2024	144	Notice of Insider Sale Intent
Apr 12, 2024	4	Insider Trading
Apr 12, 2024	4	Insider Trading
Apr 12, 2024	4	Insider Trading

Peers (Alternatives to Accolade Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	448.5B	371.6B	-0.74%	-0.51%	20.04	1.21	14.64%	11.24%
CI	103.1B	195.3B	0.26%	37.72%	19.19	0.53	8.17%	-20.79%
CVS	86.2B	357.8B	-12.72%	-6.73%	10.32	0.24	10.95%	93.52%
HCA	84.5B	65.0B	-3.19%	11.59%	16.12	1.3	7.86%	-7.11%
CNC	40.6B	154.0B	-1.43%	12.08%	15.01	0.26	6.54%	124.79%
DVA	11.7B	12.1B	-0.12%	51.97%	16.99	0.97	4.57%	23.40%
UHS	11.4B	14.3B	-8.62%	17.22%	15.93	0.8	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.2	4.12	6.06%	9.17%
ACHC	6.5B	2.9B	-7.52%	-4.24%	-301.31	2.23	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	34.21	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.6	1.45	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.94	0.44	6.74%	20.73%
BEAT	53.7M	-	-3.27%	-3.72%	-3.67	-	-	-12.94%
AMS	19.0M	21.3M	13.26%	5.28%	35.63	0.89	8.00%	-62.25%

Accolade Inc News

Latest updates

Accolade Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	2.6%	99,371,000	96,864,000	93,226,000	99,025,000	90,946,000	87,643,000	85,528,000	93,756,000	83,450,000	73,288,000	59,527,000	59,232,000	38,444,000	36,788,000	35,894,000	44,441,000	29,652,000	29,651,000	28,763,000	-
Operating Expenses	-0.2%	76,572,000	76,755,000	78,652,000	79,164,000	80,916,000	83,721,000	383,950,000	79,975,000	11,748,000	103,398,000	71,606,000	36,371,500	32,190,000	28,619,000	26,280,000	23,689,000	29,554,000	27,152,000	26,631,000	-
S&GA Expenses	8.9%	26,230,000	24,076,000	25,033,000	23,540,000	25,023,000	24,936,000	25,614,000	23,631,000	24,616,000	24,009,000	14,509,000	9,870,500	8,644,000	7,881,000	7,315,000	6,848,000	7,924,000	7,616,000	7,662,000	-
EBITDA Margin	21.8%	-0.19	-0.25	-0.29	-1.14	-1.16	-1.00	-1.13	-0.27	-0.25	-0.53	-0.35	-0.24	-	-	-	-	-	-	-	-
Interest Expenses	1409.8%	770,000	51,000	769,000	101,000	719,000	51,000	769,000	50,000	778,000	51,000	51,000	50,000	52,000	1,608,000	586,000	601,000	589,000	600,000	601,000	-
Income Taxes	294.0%	331,000	84,000	91,000	-51,000	77,000	249,000	-3,899,000	3,862,000	3,325,000	-12,845,000	19,000	-81,000	29,000	18,000	38,000	80,000	12,000	14,000	23,000	-
Earnings Before Taxes	36.7%	-20,733,000	-32,741,000	-38,318,000	-30,484,000	-39,795,000	-46,274,000	-346,721,000	-30,694,000	25,828,000	-75,209,000	-48,688,000	-4,807,000	-16,566,000	-15,353,000	-13,922,000	-2,059,000	-18,285,000	-15,012,000	-15,880,000	-
EBT Margin	15.4%	-0.31	-0.37	-0.42	-1.28	-1.30	-1.14	-1.27	-0.42	-0.37	-0.63	-0.44	-0.30	-	-	-	-	-	-	-	-
Net Income	35.8%	-21,064,000	-32,825,000	-38,409,000	-30,433,000	-39,872,000	-46,523,000	-342,822,000	-34,556,000	22,503,000	-62,364,000	-48,707,000	-4,726,000	-16,595,000	-15,371,000	-13,960,000	-2,139,000	-18,297,000	-15,026,000	-15,903,000	-
Net Income Margin	15.2%	-0.32	-0.37	-0.42	-1.27	-1.30	-1.15	-1.24	-0.40	-0.34	-0.57	-0.44	-0.30	-	-	-	-	-	-	-	-
Free Cashflow	135.8%	3,270,000	-9,126,000	-20,164,000	-2,763,000	-5,188,000	-3,892,000	-30,967,000	-2,508,000	-22,146,000	-11,902,000	-28,315,000	9,905,000	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																	(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q1
Assets	-8.1%	785	854	876	903	914	932	944	1,286	1,263	1,270	891	476	467	267	120	73.00	66.00
Current Assets	-19.1%	272	336	348	366	366	375	378	409	408	418	453	454	445	243	97.00	49.00	47.00
Cash Equivalents	-21.3%	230	292	303	321	326	331	336	366	366	384	326	434	419	222	78.00	33.00	43.00
Net PPE	7.9%	19.00	18.00	17.00	15.00	14.00	12.00	12.00	12.00	12.00	12.00	12.00	9.00	10.00	12.00	13.00	14.00	15.00
Goodwill	0%	278	278	278	278	278	278	278	578	580	6.00	366	4.00	4.00	4.00	4.00	4.00	-
Liabilities	-15.8%	351	417	422	429	428	425	410	430	475	536	454	85.00	79.00	75.00	154	97.00	82.00
Current Liabilities	6.1%	116	109	113	119	117	113	95.00	112	185	249	167	79.00	73.00	69.00	75.00	70.00	57.00
Shareholder's Equity	-0.7%	435	438	454	474	486	506	535	856	789	734	437	391	388	192	-	-	-
Retained Earnings	-2.1%	-1,046	-1,025	-992	-954	-923	-883	-837	-494	-460	-482	-420	-371	-366	-350	-334	-320	-269
Additional Paid-In Capital	1.2%	1,481	1,463	1,447	1,428	1,410	1,390	1,372	1,350	1,249	1,216	857	762	755	542	68.00	64.00	39.00
Shares Outstanding	1.2%	77.00	76.00	75.00	73.00	71.00	70.00	70.00	67.00	63.00	61.00	58.00	29.00	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																				(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	164.8%	5,205	-8,038	-19,287	-2,559	-4,692	-2,993	-30,461	-2,284	-21,422	-11,030	-27,614	10,396	-12,273	-15,038	-8,317	-10,264	-3,581	-3,522	-16,880	-
Share Based Compensation	-0.5%	15,644	15,726	14,278	17,835	17,906	17,514	19,389	27,112	18,377	19,775	7,675	3,266	2,946	2,105	1,259	1,107	1,564	1,895	1,436	-
Cashflow From Investing	-13.0%	-3,712	-3,286	-3,377	-2,413	-1,911	-1,632	-1,272	-532	721	64,910	-328,712	-491	-519	-875	-538	-846	-1,405	-1,161	-109	-
Cashflow From Financing	-10031.8%	-63,663	641	4,451	418	1,607	-370	1,508	2,687	2,680	4,615	247,950	5,041	209,619	160,342	53,382	4,611	20,710	2,556	345	-

ACCD Income Statement

2023-11-30

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Income Statement [Abstract]
Revenue	$ 99,371,000	$ 90,946,000	$ 289,461,000	$ 264,117,000
Cost of revenue, excluding depreciation and amortization	54,518,000	50,412,000	164,038,000	147,857,000
Operating expenses:
Product and technology	23,468,000	24,254,000	74,969,000	77,265,000
Sales and marketing	26,230,000	25,023,000	75,339,000	75,573,000
General and administrative	15,474,000	20,037,000	47,813,000	61,295,000
Depreciation and amortization	11,400,000	11,602,000	33,858,000	34,749,000
Goodwill impairment	0	0	0	299,705,000
Total operating expenses	76,572,000	80,916,000	231,979,000	548,587,000
Loss from operations	(31,719,000)	(40,382,000)	(106,556,000)	(432,327,000)
Interest income (expense), net	1,705,000	386,000	4,340,000	(484,000)
Other income (expense)	9,281,000	201,000	10,424,000	21,000
Loss before income taxes	(20,733,000)	(39,795,000)	(91,792,000)	(432,790,000)
Income tax benefit (expense)	(331,000)	(77,000)	(506,000)	3,573,000
Net loss	$ (21,064,000)	$ (39,872,000)	$ (92,298,000)	$ (429,217,000)
Net loss per share, basic (USD per share)	$ (0.28)	$ (0.56)	$ (1.24)	$ (6.07)
Net loss per share, diluted (USD per share)	$ (0.28)	$ (0.56)	$ (1.24)	$ (6.07)
Weighted-average common shares outstanding - basic (in shares)	76,139,256	71,228,351	74,572,094	70,755,157
Weighted-average common shares outstanding - diluted (in shares)	76,139,256	71,228,351	74,572,094	70,755,157

ACCD Balance Sheet

2023-11-30

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Nov. 30, 2023	Feb. 28, 2023
Current assets:
Cash and cash equivalents	$ 230,017	$ 321,083
Accounts receivable, net	23,195	23,435
Unbilled revenue	2,362	3,260
Current portion of deferred contract acquisition costs	4,462	4,022
Prepaid and other current assets	12,054	14,149
Total current assets	272,090	365,949
Property and equipment, net	19,223	14,763
Operating lease right-of-use assets	28,847	29,525
Goodwill	278,191	278,191
Intangible assets, net	174,548	203,202
Deferred contract acquisition costs	9,588	9,815
Other assets	2,984	1,624
Total assets	785,471	903,069
Current liabilities:
Accounts payable	12,667	10,155
Accrued expenses and other current liabilities	8,334	11,744
Accrued compensation	25,911	39,346
Due to customers	9,085	15,694
Current portion of deferred revenue	52,772	35,191
Current portion of operating lease liabilities	6,900	7,284
Total current liabilities	115,669	119,414
Loans payable, net of unamortized issuance costs	208,178	282,323
Operating lease liabilities	26,620	27,189
Other noncurrent liabilities	165	203
Deferred revenue	120	154
Total liabilities	350,752	429,283
Commitments and Contingencies (note 10)
Stockholders’ equity
Common stock par value $0.0001; 500,000,000 shares authorized; 76,966,368 and 73,089,075 shares issued and outstanding at November 30, 2023 and February 28, 2023, respectively	8	7
Additional paid-in capital	1,481,303	1,428,073
Accumulated deficit	(1,046,592)	(954,294)
Total stockholders’ equity	434,719	473,786
Total liabilities and stockholders’ equity	$ 785,471	$ 903,069

About Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

CEO	Mr. Rajeev Singh
WEBSITE	accolade.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2370

Accolade Inc Frequently Asked Questions

What is the ticker symbol for Accolade Inc? What does ACCD stand for in stocks?

ACCD is the stock ticker symbol of Accolade Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Accolade Inc (ACCD)?

As of Tue Apr 23 2024, market cap of Accolade Inc is 723.76 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ACCD stock?

You can check ACCD's fair value in chart for subscribers.

What is the fair value of ACCD stock?

You can check ACCD's fair value in chart for subscribers. The fair value of Accolade Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Accolade Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ACCD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Accolade Inc a good stock to buy?

The fair value guage provides a quick view whether ACCD is over valued or under valued. Whether Accolade Inc is cheap or expensive depends on the assumptions which impact Accolade Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACCD.

What is Accolade Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, ACCD's PE ratio (Price to Earnings) is -5.9 and Price to Sales (PS) ratio is 1.86. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACCD PE ratio will change depending on the future growth rate expectations of investors.